What are the Challenges in Developing Nanotechnology-Based Combination Therapies?
Despite their potential, there are several challenges in developing nanotechnology-based combination therapies:
Complex Manufacturing: The production of multifunctional nanoparticles with precise control over size, shape, and surface properties is complex and expensive. Toxicity Concerns: The long-term safety and biocompatibility of nanomaterials must be thoroughly evaluated to avoid unintended toxic effects. Regulatory Hurdles: The approval process for combination therapies involving nanotechnology is complex and requires extensive preclinical and clinical testing.
